Remarkably, despite the small number of patients with recurrence, serial profiling of plasma exosomes indicated that PD-L1+ exosomes were the highly significant and most consistent early indicator of successful treatment in HNSCC patients enrolled in the study. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.